Increasing treatment time on REMICADE (R) (infliximab) predicts subsequent long-term retention in stable infliximab inflammatory bowel disease patients in Canada
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- February 1, 2017
has subject area
- 1103 Clinical Sciences (FoR)
- Gastroenterology & Hepatology (Science Metrix)
published in
- Journal of Crohn's and Colitis Journal